Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Generation Bio (GBIO) Receivables (2022 - 2025)

Historic Receivables for Generation Bio (GBIO) over the last 4 years, with Q3 2025 value amounting to $746000.0.

  • Generation Bio's Receivables fell 6627.49% to $746000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $746000.0, marking a year-over-year decrease of 6627.49%. This contributed to the annual value of $3.5 million for FY2024, which is 1101.01% down from last year.
  • As of Q3 2025, Generation Bio's Receivables stood at $746000.0, which was down 6627.49% from $445000.0 recorded in Q2 2025.
  • Over the past 5 years, Generation Bio's Receivables peaked at $49.3 million during Q1 2023, and registered a low of $340000.0 during Q2 2023.
  • Over the past 4 years, Generation Bio's median Receivables value was $1.3 million (recorded in 2024), while the average stood at $5.1 million.
  • Within the past 5 years, the most significant YoY rise in Generation Bio's Receivables was 90253.16% (2023), while the steepest drop was 8087.74% (2023).
  • Generation Bio's Receivables (Quarter) stood at $395000.0 in 2022, then skyrocketed by 902.53% to $4.0 million in 2023, then tumbled by 38.18% to $2.4 million in 2024, then plummeted by 69.53% to $746000.0 in 2025.
  • Its last three reported values are $746000.0 in Q3 2025, $445000.0 for Q2 2025, and $2.7 million during Q1 2025.